Technology from a Mount Sinai Startup (Cardea Sciences) That Will Improve Outcomes for Cardiac Patients Wins the NYC Life Science Innovation Showcase
Technology for identifying at-risk atrial fibrillation (AFib) patients was chosen as the winner of the inaugural Alexandria LaunchLabs Scholarship Award, which recognizes excellence in health care technology, entrepreneurship and business competencies. The technology, developed by a Mount Sinai researcher and entrepreneur, Ya-El Mandel-Portnoy, PhD, was selected from entries submitted by 26 of New York City’s top academic entrepreneurs, who presented their work to investors and biopharma business executives at the 2017 NYC Life Science Innovation Showcase on June 13, 2017.
Dr. Mandel-Portnoy launched Cardea Sciences, a startup addressing the critical unmet medical need of effectively stratifying patients with AFib—the most common cardiac arrhythmia, costing the United States an estimated $26 billion annually—during her doctorate program at the Icahn School of Medicine at Mount Sinai. Her winning technology will help patients and care providers to better manage AFib in an outpatient setting by measuring pulse deficit—the difference in the heart rate between key areas in the body—and segmenting AFib patients based on the magnitude of their pulse deficit.
“Cardea Sciences’ focus is on patient outcomes, empowering patients and clinicians to manage the disease by identifying those AFib patients who will not tolerate the arrhythmia well and will suffer from severe adverse events,” said Dr. Mandel-Portnoy. “This will help care providers optimize their course of treatment and reduce the number of readmissions, thus leading to a reduction in health care costs.”
As the Alexandria LaunchLabs Scholarship Award winner, Dr. Mandel-Portnoy will receive laboratory and office space at the innovative Alexandria LaunchLabs, New York City’s premier, full-service life science startup platform at the Alexandria Center for Life Science – New York City.
“Dr. Mandel-Portnoy is a product of the innovation ecosystem that we’ve built at Mount Sinai. We are thrilled that Cardea Sciences was recognized by Alexandria LaunchLabs and look forward to its success,” said Erik Lium, PhD, Senior Vice President of Mount Sinai Innovation Partners, the commercialization arm of the Icahn School of Medicine at Mount Sinai.
The NYC Life Science Innovation Showcase was organized by Alexandria Real Estate Equities, Inc., an urban office REIT focused on collaborative life science and technology campuses, in partnership with the New York Academic Consortium.
“We are thrilled to have Dr. Mandel-Portnoy bring her passion and excitement for entrepreneurship to the Alexandria LaunchLabs community and are committed to helping her build a successful company around her promising AFib technology,” said Blake Stevens, PhD, general manager of Alexandria LaunchLabs.
About Mount Sinai Innovation Partners (MSIP)
MSIP is responsible for driving the real-world application and commercialization of Mount Sinai discoveries and the development of research partnerships with industry. The aim is to translate these innovations into healthcare products and services that benefit patients and society. MSIP is responsible for the full spectrum of commercialization activities required to bring the Icahn School of Medicine and the Mount Sinai Health System’s inventions to life. These activities include evaluating, patenting, marketing and licensing new technologies, engaging commercial and non-profit relationships for sponsored research, material transfer and confidentiality, as well as fostering an ecosystem of entrepreneurship within our research and health system communities. For more information, visit www.ip.mountsinai.org.
About Alexandria LaunchLabs at the Alexandria Center for Life Science – New York City
Alexandria LaunchLabs is New York City’s premier, full-service startup platform designed to satisfy key unmet needs for plug-and-play space and strategic risk capital for seed- and early-stage life science companies in New York City. Located at the Alexandria Center for Life Science – New York City, Alexandria LaunchLabs provides move-in-ready office/laboratory space, first-class support resources, shared equipment and services, creative amenities and access to startup capital through the Alexandria Seed Capital Platform—all of which are critical for accelerating the growth of seed- and early-stage companies in New York City. The Alexandria LaunchLabs team continues to accept applications for future members. For more information, please visit www.launchlabsnyc.com.
About the Mount Sinai Health System
The Mount Sinai Health System is New York City's largest integrated delivery system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai's vision is to produce the safest care, the highest quality, the highest satisfaction, the best access and the best value of any health system in the nation. The Health System includes approximately 7,480 primary and specialty care physicians; 11 joint-venture ambulatory surgery centers; more than 410 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. The Icahn School of Medicine is one of three medical schools that have earned distinction by multiple indicators: ranked in the top 20 by U.S. News & World Report's "Best Medical Schools", aligned with a U.S. News & World Report's "Honor Roll" Hospital, No. 12 in the nation for National Institutes of Health funding, and among the top 10 most innovative research institutions as ranked by the journal Nature in its Nature Innovation Index. This reflects a special level of excellence in education, clinical practice, and research. The Mount Sinai Hospital is ranked No. 18 on U.S. News & World Report's "Honor Roll" of top U.S. hospitals; it is one of the nation's top 20 hospitals in Cardiology/Heart Surgery, Gastroenterology/GI Surgery, Geriatrics, Nephrology, and Neurology/Neurosurgery, and in the top 50 in six other specialties in the 2018-2019 "Best Hospitals" issue. Mount Sinai's Kravis Children's Hospital also is ranked nationally in five out of ten pediatric specialties by U.S. News & World Report. The New York Eye and Ear Infirmary of Mount Sinai is ranked 11th nationally for Ophthalmology and 44th for Ear, Nose, and Throat. Mount Sinai Beth Israel, Mount Sinai St. Luke's, Mount Sinai West, and South Nassau Communities Hospital are ranked regionally.